Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma

The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerchione, Claudio, Nappi, Davide, Di Perna, Maria, Zacheo, Irene, Pareto, Anna Emanuele, Picardi, Marco, Catalano, Lucio, Pane, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102715/
https://www.ncbi.nlm.nih.gov/pubmed/27867671
http://dx.doi.org/10.1155/2016/6745286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102715/
https://www.ncbi.nlm.nih.gov/pubmed/27867671
http://dx.doi.org/10.1155/2016/6745286

Ejemplares similares